Mažerik J - Search Results

1

Chemical characteristics and significant antitussive effect of the Erigeron canadensis polyphenolic polysaccharide-protein complex.

Šutovská M, Kocmálová M, Mažerik J, Pawlaczyk-Graja I, Gancarz R, Capek P. Šutovská M, et al. Among authors: mazerik j. J Ethnopharmacol. 2022 Feb 10;284:114754. doi: 10.1016/j.jep.2021.114754. Epub 2021 Oct 16. J Ethnopharmacol. 2022. PMID: 34662663

2

The anti-asthmatic potential of Rho-kinase inhibitor hydroxyfasudil in the model of experimentally induced allergic airway inflammation.

Franova S, Molitorisova M, Kalmanova L, Palencarova J, Joskova M, Smiesko L, Mazerik J, Sutovska M. Franova S, et al. Among authors: mazerik j. Eur J Pharmacol. 2023 Jan 5;938:175450. doi: 10.1016/j.ejphar.2022.175450. Epub 2022 Dec 5. Eur J Pharmacol. 2023. PMID: 36473595

3

Effects of TRPV4 channel blocker on airway inflammation and airway defense reflexes in experimentally induced model of allergic asthma.

Mažerik J, Gondáš E, Smieško L, Fraňová S, Šutovská M. Mažerik J, et al. Respir Physiol Neurobiol. 2023 Oct;316:104123. doi: 10.1016/j.resp.2023.104123. Epub 2023 Jul 24. Respir Physiol Neurobiol. 2023. PMID: 37495166 Free article.

4

Dendrobium officinale polysaccharides-chemical properties and pharmacodynamic effects on the airways in experimental conditions.

Šutovská M, Mažerik J, Kocmálová M, Uhliariková I, Matulová M, Capek P. Šutovská M, et al. Among authors: mazerik j. Arch Pharm (Weinheim). 2024 Mar;357(3):e2300537. doi: 10.1002/ardp.202300537. Epub 2023 Dec 14. Arch Pharm (Weinheim). 2024. PMID: 38096806

5

3-D retina organoids: Building platforms for therapies of the future.

Mazerik JN, Becker S, Sieving PA. Mazerik JN, et al. Cell Med. 2018 Jun 8;10:2155179018773758. doi: 10.1177/2155179018773758. eCollection 2018. Cell Med. 2018. PMID: 32634188 Free PMC article.

6

CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network.

Aksoy BA, Dancík V, Smith K, Mazerik JN, Ji Z, Gross B, Nikolova O, Jaber N, Califano A, Schreiber SL, Gerhard DS, Hermida LC, Jagu S, Sander C, Floratos A, Clemons PA. Aksoy BA, et al. Among authors: mazerik jn. Database (Oxford). 2017 Jan 1;2017:bax054. doi: 10.1093/database/bax054. Database (Oxford). 2017. PMID: 29220450 Free PMC article.

7

Motor and tail homology 1 (Th1) domains antagonistically control myosin-1 dynamics.

Mazerik JN, Kraft LJ, Kenworthy AK, Tyska MJ. Mazerik JN, et al. Biophys J. 2014 Feb 4;106(3):649-58. doi: 10.1016/j.bpj.2013.12.038. Biophys J. 2014. PMID: 24507605 Free PMC article.

8

Membrane-bound myo1c powers asymmetric motility of actin filaments.

Pyrpassopoulos S, Feeser EA, Mazerik JN, Tyska MJ, Ostap EM. Pyrpassopoulos S, et al. Among authors: mazerik jn. Curr Biol. 2012 Sep 25;22(18):1688-92. doi: 10.1016/j.cub.2012.06.069. Epub 2012 Aug 2. Curr Biol. 2012. PMID: 22863317 Free PMC article.

9

Myosin-1A targets to microvilli using multiple membrane binding motifs in the tail homology 1 (TH1) domain.

Mazerik JN, Tyska MJ. Mazerik JN, et al. J Biol Chem. 2012 Apr 13;287(16):13104-15. doi: 10.1074/jbc.M111.336313. Epub 2012 Feb 24. J Biol Chem. 2012. PMID: 22367206 Free PMC article.

10

Lipoxygenase-catalyzed phospholipid peroxidation: preparation, purification, and characterization of phosphatidylinositol peroxides.

O'Connor Butler ES, Mazerik JN, Cruff JP, Sherwani SI, Weis BK, Marsh CB, Raghavamenon AC, Uppu RM, Schmid HH, Parinandi NL. O'Connor Butler ES, et al. Among authors: mazerik jn. Methods Mol Biol. 2010;610:387-401. doi: 10.1007/978-1-60327-029-8_23. Methods Mol Biol. 2010. PMID: 20013191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page